{"id":1909631,"date":"2014-02-01T11:28:32","date_gmt":"2014-02-01T05:58:32","guid":{"rendered":"http:\/\/stockviz.biz\/index.php\/?p=1909631"},"modified":"2014-02-01T11:28:32","modified_gmt":"2014-02-01T05:58:32","slug":"monthly-recap-levee-breaks","status":"publish","type":"post","link":"https:\/\/stockviz.biz\/index.php\/2014\/02\/01\/monthly-recap-levee-breaks\/","title":{"rendered":"Monthly Recap: The levee breaks"},"content":{"rendered":"

\"nifty<\/a><\/p>\n

The Nifty ended the month -3.40%<\/strong><\/span> (-4.30%<\/strong><\/span> in USD terms.)<\/p>\n

Index Performance<\/h3>\n

IT was the only place to be long… everything else was just wrong.<\/p>\n

\"monthly<\/a><\/p>\n

Top Winners and losers<\/h3>\n
\n
\n\n\n\n\n\n\n\n\n
DIVISLAB<\/a><\/td>\n+7.71%<\/span><\/td>\n<\/tr>\n
UBL<\/a><\/td>\n+7.83%<\/span><\/td>\n<\/tr>\n
HCLTECH<\/a><\/td>\n+15.81%<\/span><\/td>\n<\/tr>\n
RANBAXY<\/a><\/td>\n-28.65%<\/span><\/td>\n<\/tr>\n
JPASSOCIAT<\/a><\/td>\n-26.08%<\/span><\/td>\n<\/tr>\n
CANBK<\/a><\/td>\n-21.65%<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n
Well done HCL Tech, well done. Ranbaxy got tagged by the US FDA and JP Associates is the leading contender for one of the biggest break-downs this year.<\/div>\n<\/div>\n

ETFs<\/h3>\n
\n
\n\n\n\n\n\n\n\n\n
GOLDBEES<\/a><\/td>\n+1.77%<\/span><\/td>\n<\/tr>\n
NIFTYBEES<\/a><\/td>\n-3.18%<\/span><\/td>\n<\/tr>\n
INFRABEES<\/a><\/td>\n-4.53%<\/span><\/td>\n<\/tr>\n
JUNIORBEES<\/a><\/td>\n-6.81%<\/span><\/td>\n<\/tr>\n
BANKBEES<\/a><\/td>\n-9.68%<\/span><\/td>\n<\/tr>\n
PSUBNKBEES<\/a><\/td>\n-13.23%<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n
Brutal.<\/div>\n<\/div>\n

Advancers and Decliners<\/h3>\n

\"advance<\/p>\n

Yield Curve<\/h3>\n

\"india<\/a><\/p>\n

Investment Theme Performance<\/h3>\n
\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Velocity*<\/a><\/td>\n+3.60%<\/span><\/td>\n<\/tr>\n
Balance-sheet Strength<\/a><\/td>\n+0.09%<\/span><\/td>\n<\/tr>\n
Financial Strength Value<\/a><\/td>\n-1.07%<\/span><\/td>\n<\/tr>\n
Momentum 200<\/a><\/td>\n-1.13%<\/span><\/td>\n<\/tr>\n
Efficient Growth<\/a><\/td>\n-1.18%<\/span><\/td>\n<\/tr>\n
Consistent10*<\/a><\/td>\n-1.69%<\/span><\/td>\n<\/tr>\n
Market Elephants<\/a><\/td>\n-1.82%<\/span><\/td>\n<\/tr>\n
Enterprise Yield<\/a><\/td>\n-3.27%<\/span><\/td>\n<\/tr>\n
Magic Formula Investing<\/a><\/td>\n-3.62%<\/span><\/td>\n<\/tr>\n
Growth with Moat<\/a><\/td>\n-5.13%<\/span><\/td>\n<\/tr>\n
ADAG Mania<\/a><\/td>\n-5.60%<\/span><\/td>\n<\/tr>\n
Long Term Equity*<\/a><\/td>\n-5.85%<\/span><\/td>\n<\/tr>\n
Quality to Price<\/a><\/td>\n-8.83%<\/span><\/td>\n<\/tr>\n
Market Fliers<\/a><\/td>\n-13.90%<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n
Momentum carried the month.<\/div>\n<\/div>\n

Sector Performance<\/h3>\n

\"monthly<\/a><\/p>\n

Thought to sum up the month<\/h3>\n

Well, we had too much to drink (infrastructure debt binge, etc.) before the GFC and spent the rest of the next 5 years barely recovering (NPAs, capital raises, etc.) from the hangover. But it looks like we are going to get trampled by the herd again.<\/p><\/blockquote>\n

 <\/p>\n

Source: The levee breaks<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

The Nifty ended the month -3.40% (-4.30% in USD terms.) Index Performance IT was the only place to be long… everything else was just wrong. Top Winners and losers DIVISLAB +7.71% UBL +7.83% HCLTECH +15.81% RANBAXY -28.65% JPASSOCIAT -26.08% CANBK -21.65% Well done HCL Tech, well done. Ranbaxy got tagged by the US FDA and … <\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[9],"tags":[1881],"class_list":["post-1909631","post","type-post","status-publish","format-standard","hentry","category-your-money","tag-monthly","entry"],"_links":{"self":[{"href":"https:\/\/stockviz.biz\/index.php\/wp-json\/wp\/v2\/posts\/1909631","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stockviz.biz\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stockviz.biz\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stockviz.biz\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stockviz.biz\/index.php\/wp-json\/wp\/v2\/comments?post=1909631"}],"version-history":[{"count":0,"href":"https:\/\/stockviz.biz\/index.php\/wp-json\/wp\/v2\/posts\/1909631\/revisions"}],"wp:attachment":[{"href":"https:\/\/stockviz.biz\/index.php\/wp-json\/wp\/v2\/media?parent=1909631"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stockviz.biz\/index.php\/wp-json\/wp\/v2\/categories?post=1909631"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stockviz.biz\/index.php\/wp-json\/wp\/v2\/tags?post=1909631"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}